PURPOSE: Infection is ubiquitous and a major cause of morbidity and mortality. The most reliable method for localizing infection requires radiolabeling autologous white blood cells ex vivo. A compound that can be injected directly into a patient and can selectively image infectious foci will eliminate the drawbacks. The resolution of infection is associated with neutrophil apoptosis and necrosis presenting phosphatidylserine (PS) on the neutrophil outer leaflet. Targeting PS with intravenous administration of a PS-specific, near-infrared (NIR) fluorophore will permit localization of infectious foci by optical imaging. METHODS: Bacterial infection and sterile inflammation were induced in separate groups (n = 5) of mice. PS was targeted with a NIR fluorophore, PSVue(®)794 (2.7 pmol). Imaging was performed (ex = 730 nm, em = 830 nm) using Kodak Multispectral FX-Pro system. The contralateral normal thigh served as an individualized control. Confocal microscopy of normal and apoptotic neutrophils and bacteria confirmed PS specificity. RESULTS: Lesions, with a 10-s image acquisition, were unequivocally visible at 5 min post-injection. At 3 h post-injection, the lesion to background intensity ratios in the foci of infection (6.6 ± 0.2) were greater than those in inflammation (3.2 ± 0.5). Image fusions confirmed anatomical locations of the lesions. Confocal microscopy determined the fluorophore specificity for PS. CONCLUSIONS: Targeting PS presented on the outer leaflet of apoptotic or necrotic neutrophils as well as gram-positive microorganism with PS-specific NIR fluorophore provides a sensitive means of imaging infection. Literature indicates that NIR fluorophores can be detected 7-14 cm deep in tissue. This observation together with the excellent results and the continued development of versatile imaging devices could make optical imaging a simple, specific, and rapid modality for imaging infection.
PURPOSE:Infection is ubiquitous and a major cause of morbidity and mortality. The most reliable method for localizing infection requires radiolabeling autologous white blood cells ex vivo. A compound that can be injected directly into a patient and can selectively image infectious foci will eliminate the drawbacks. The resolution of infection is associated with neutrophil apoptosis and necrosis presenting phosphatidylserine (PS) on the neutrophil outer leaflet. Targeting PS with intravenous administration of a PS-specific, near-infrared (NIR) fluorophore will permit localization of infectious foci by optical imaging. METHODS:Bacterial infection and sterile inflammation were induced in separate groups (n = 5) of mice. PS was targeted with a NIR fluorophore, PSVue(®)794 (2.7 pmol). Imaging was performed (ex = 730 nm, em = 830 nm) using Kodak Multispectral FX-Pro system. The contralateral normal thigh served as an individualized control. Confocal microscopy of normal and apoptotic neutrophils and bacteria confirmed PS specificity. RESULTS: Lesions, with a 10-s image acquisition, were unequivocally visible at 5 min post-injection. At 3 h post-injection, the lesion to background intensity ratios in the foci of infection (6.6 ± 0.2) were greater than those in inflammation (3.2 ± 0.5). Image fusions confirmed anatomical locations of the lesions. Confocal microscopy determined the fluorophore specificity for PS. CONCLUSIONS: Targeting PS presented on the outer leaflet of apoptotic or necrotic neutrophils as well as gram-positive microorganism with PS-specific NIR fluorophore provides a sensitive means of imaging infection. Literature indicates that NIR fluorophores can be detected 7-14 cm deep in tissue. This observation together with the excellent results and the continued development of versatile imaging devices could make optical imaging a simple, specific, and rapid modality for imaging infection.
Authors: W Matthew Leevy; Seth T Gammon; Hua Jiang; James R Johnson; Dustin J Maxwell; Erin N Jackson; Manuel Marquez; David Piwnica-Worms; Bradley D Smith Journal: J Am Chem Soc Date: 2006-12-27 Impact factor: 15.419
Authors: M L Thakur; C S Marcus; S L Kipper; R Ahdoot; L Diggles; H L Pham; C Minami; M C Patel; T Smith Journal: Nucl Med Commun Date: 2001-05 Impact factor: 1.690
Authors: David L Penn; Christopher Kim; Kaijun Zhang; Archana Mukherjee; Devadhas Devakumar; Donald Jungkind; Mathew L Thakur Journal: Nucl Med Biol Date: 2009-10-03 Impact factor: 2.408
Authors: Léa Fialkow; Luciano Fochesatto Filho; Mary C Bozzetti; Adriana R Milani; Edison M Rodrigues Filho; Roberta M Ladniuk; Paula Pierozan; Rafaela M de Moura; João C Prolla; Eric Vachon; Gregory P Downey Journal: Crit Care Date: 2006 Impact factor: 9.097
Authors: Douglas R Rice; Adam J Plaunt; Serhan Turkyilmaz; Miles Smith; Yuzhen Wang; Mary Rusckowski; Bradley D Smith Journal: Mol Imaging Biol Date: 2015-04 Impact factor: 3.488
Authors: Jacky M K Kwong; Celia Hoang; Reshil T Dukes; Richard W Yee; Brian D Gray; Koon Y Pak; Joseph Caprioli Journal: Invest Ophthalmol Vis Sci Date: 2014-07-17 Impact factor: 4.799
Authors: Egor Bobrov; Natalia Skobeleva; Diana Restifo; Natalya Beglyarova; Kathy Q Cai; Elizabeth Handorf; Kerry Campbell; David A Proia; Vladimir Khazak; Erica A Golemis; Igor Astsaturov Journal: Oncotarget Date: 2017-01-17
Authors: Marjolein Heuker; Anna Gomes; Jan Maarten van Dijl; Gooitzen M van Dam; Alexander W Friedrich; Bhanu Sinha; Marleen van Oosten Journal: Clin Transl Imaging Date: 2016-07-16